Acknowledgements
Medical writing support in the preparation of this manuscript was provided by Susie Eaton, MBio, and Tom Priddle, DPhil, of OPEN Health Communications (UK), funded by Boehringer Ingelheim. We thank all the participants and study investigators for their participation in this trial. Survodutide was co-invented with Zealand Pharma. Data from some sections of this article were previously presented at the 58th EASD Annual Meeting in 2022 and at ObesityWeek 2022.